Jump to navigation
Biologic drugs shouldn’t get extended monopolies, they say.
Australia is leading the way in the global response to hep C. with tens of thousands of Australians cured since...
Have you tried it?
That's in addition to three new listings in February.
The government is paying too much for pharmaceuticals that are no better than their cheaper counterparts. Let’s fix...
A real-world trial provides some reassuring evidence.
The price requested for Truvada is too high, PBAC rules.
And several drugs are now indicated for triple oral therapy
Endocrinologist fears Australia will miss out on innovative treatments
When it comes to rare cancers, the scheme falls short, writes Professor Ian Olver.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.